疫苗前沿 | 美国16岁以上人群可接种增强针，FDA扩展辉瑞/BioNTech新冠疫苗紧急使用授权

 

参考资料:

[1] Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older. Retrieved December 9, 2021, from https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-us-fda-emergency-use

[2] Pfizer And Biontech Announce Phase 3 Trial Data Showing High Efficacy Of A Booster Dose Of Their Covid-19 Vaccine. Retrieved October 21, from https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-phase-3-trial-data-showing

图文来源：药明康德

打赏